NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.3 Anti-lymphocyte monoclonal antibodies > Multiple sclerosis (relapsing-remitting) - alemtuzumab NICE TAG TA312

Multiple sclerosis (relapsing-remitting) - alemtuzumab NICE TAG TA312

1.1 Alemtuzumab is recommended as an option, within its marketing authorisation, for treating adults with active relapsing–remitting multiple sclerosis.

https://www.nice.org.uk/guidance/TA312

Site by Devopa
© Copyright 2019 NHS. All rights reserved.